主动脉瓣狭窄患者心肌纤维化与死亡率的性别特异性关联
该前瞻性多中心研究纳入822例重度主动脉瓣狭窄患者(670例无阻塞性冠心病),在主动脉瓣置换术前用心脏磁共振评估心肌纤维化。女性与男性细胞外容积分数相似但晚期钆增强较少;细胞外容积分数和晚期钆增强升高与男女全因及心血管死亡风险增加相关,无显著性别交互作用。
要点
- 重度主动脉瓣狭窄患者中,女性与男性细胞外容积分数相似,但女性晚期钆增强较少。
- 细胞外容积分数和晚期钆增强升高与男女全因死亡风险增加相关,无显著性别交互作用。
- 晚期钆增强存在时女性全因死亡调整风险比2.49,男性1.82。
核心结论
- 重度主动脉瓣狭窄行主动脉瓣置换术患者中,男女细胞外容积分数相似,女性晚期钆增强较少。
- 心肌纤维化指标升高对男女均有重要预后价值,无显著性别交互作用。
研究设计与样本
- 前瞻性多中心研究,2011年3月至2021年9月从13个国际中心纳入重度主动脉瓣狭窄行主动脉瓣置换术前接受心脏磁共振的患者。
- 主要分析基于无阻塞性冠心病患者(无心肌梗死病史且未同期行冠状动脉旁路移植术),共670例(男性368例[55%],女性302例[45%])。
主要发现
- 无阻塞性冠心病患者中位随访3.7年(IQR 2.1-4.7),发生76例死亡(11.3%),其中心血管死亡29例。
- 细胞外容积分数每增加1%,女性全因死亡调整风险比1.08(95%CI 1.04-1.12,P<.001),男性1.01(95%CI 0.96-1.06,P=.66),性别交互P=.09。
- 晚期钆增强存在时,女性全因死亡调整风险比2.49(95%CI 1.07-5.80,P=.03),男性1.82(95%CI 1.00-3.32,P=.04),性别交互P=.68。
- 全部822例人群中,非梗死性和梗死性晚期钆增强均与死亡率增加相关,无显著性别交互作用。
临床怎么用
- 主动脉瓣置换术前心脏磁共振评估的细胞外容积分数和晚期钆增强可提供预后信息,男女均应关注。
- 女性晚期钆增强较少但预后意义显著,解读纤维化指标时需考虑性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Myocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear. OBJECTIVE: To investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS. DESIGN, SETTING, AND PARTICIPANTS: Patients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024. EXPOSURES: Surgical or transcatheter AVR. MAIN OUTCOMES AND MEASURES: The primary outcome was post-AVR all-cause mortality and the secondary outcome was cardiovascular mortality. RESULTS: Of 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; P < .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; P = .66; P for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; P = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; P = .04; P for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex. CONCLUSIONS AND RELEVANCE: In this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.
引用
- Kwak S, Singh A, Everett RJ, et al. Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis. JAMA Cardiol. 2025. PMID: 39969863. doi:10.1001/jamacardio.2024.5593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。